Navigation Links
FDA Advisory Committee Unanimously Recommends Approval of Ustekinumab for Treatment of Moderate to Severe Plaque Psoriasis
Date:6/17/2008

HORSHAM, Pa., June 17 /PRNewswire/ -- Centocor, Inc. announced today that the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) of the U.S. Food and Drug Administration (FDA) has unanimously recommended the approval of ustekinumab, a new subcutaneous, investigational biologic therapy for the treatment of adult patients with moderate to severe plaque psoriasis. Ustekinumab is a new human monoclonal antibody with a novel mechanism of action that targets the cytokines interleukin-12 (IL-12) and interleukin-23 (IL-23), naturally occurring proteins that are important in the body's regulation of immune responses and that are also believed to play an important role in psoriasis.

"We are very pleased with the advisory committee's support for the approval of ustekinumab," stated Jerome A. Boscia, M.D., Senior Vice President, Clinical, Centocor R&D. "For many patients, psoriasis is a serious disease, and they are in need of additional treatment options. It is our hope that the FDA will consider this recommendation and, upon completion of its review process, make ustekinumab available to patients with moderate to severe psoriasis."

The committee reviewed data from one of the largest biologic clinical programs in psoriasis, which included two large Phase 3 multicenter, randomized, double-blind, placebo-controlled trials evaluating the safety and efficacy of ustekinumab involving more than 2,000 patients. Results of these Phase 3 trials were recently published in The Lancet, which showed that a majority of patients treated with ustekinumab experienced significant skin clearance by week 12 and sustained efficacy through at least week 76 with ustekinumab maintenance therapy every 12 weeks. In December 2007, Centocor announced that a Biologics License Application had been submitted to the FDA.

DODAC is convened on request of the FDA to review and evaluate safety and efficacy data of human drug products for use in the treatment of dermatologic
'/>"/>

SOURCE Centocor, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. UBC Forms European Advisory Board to Enhance Data Quality of CNS Trials
2. Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote
3. FDA Advisory Committee Unanimously Recommends U.S. Approval of Sugammadex, the First and Only Selective Relaxant Binding Agent
4. HUYA Bioscience Intl Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China
5. FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
6. Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
7. Schiffrin Barroway Topaz & Kessler, LLP and Janet Jenner & Suggs, LLC Comment on Conagra Advisory Regarding Pot Pies Linked to Salmonella Outbreak
8. Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Review of its Phase 1/2 Trial of tgAAC94 for Rheumatoid Arthritis
9. Statement by KCP Chairman Dr. Edward Jones in Response to FDA Advisory Committee on Benefits and Risks of Erythropoietin-Stimulating Agents in Treatment of Kidney Patients
10. FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R)
11. IDM Pharma Announces Non-Binding Opinion of the European Committee for Medicinal Products for Human Use (CHMP) that Mifamurtide (L-MTP-PE) Provides a Possible Clinical Benefit in Survival
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... , July, 29  2014 ISPE—the International Society ... John Bournas as President and CEO, ... to leave the Society last fall.  Mr. Bournas ... in the healthcare association industry as well as ... a clear vision for the expansion of its ...
(Date:7/29/2014)... , July 29, 2014  Roche (SIX: RO, ... Association for Clinical Chemistry (AACC) 2014 Clinical Lab Expo ... on the unique ways Roche is partnering with customers ... "Our customers tell us every day that they,re looking ... they deliver in their labs and offices," said ...
(Date:7/29/2014)... July 29, 2014 Research and Markets ... Respiratory Devices Market 2014-2018" report to their offering. ... A respiratory device is a medical device used to ... difficulty in breathing and cannot achieve adequate oxygen levels ... cystic fibrosis, asthma, COPD, and ARDS require the need ...
Breaking Medicine Technology:ISPE Hires Healthcare Association Exec as CEO 2ISPE Hires Healthcare Association Exec as CEO 3Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 2Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 3Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 4Global Respiratory Devices Market 2014-2018 2
... April 28, 2011 ResMed Inc. (NYSE: RMD ... ended March 31, 2011.  Revenue for the quarter ended March ... 12% increase on a constant currency basis) over the quarter ... 2011, income from operations was $64.0 million and net income ...
... Financial Highlights ($ in millions, except ... , $109.5 , 28.8% increaseTotal Net Product Revenue , ... , 24.7% increaseAldurazyme BioMarin Net Product Revenue* , $18.7 ... increaseFirdapse Net Product Revenue , $3.1 , $0.1GAAP Net ...
Cached Medicine Technology:ResMed Inc. Announces Record Financial Results for the Quarter Ended and Nine Months Ended March 31, 2011 2ResMed Inc. Announces Record Financial Results for the Quarter Ended and Nine Months Ended March 31, 2011 3ResMed Inc. Announces Record Financial Results for the Quarter Ended and Nine Months Ended March 31, 2011 4ResMed Inc. Announces Record Financial Results for the Quarter Ended and Nine Months Ended March 31, 2011 5ResMed Inc. Announces Record Financial Results for the Quarter Ended and Nine Months Ended March 31, 2011 6BioMarin Announces First Quarter 2011 Financial Results 2BioMarin Announces First Quarter 2011 Financial Results 3BioMarin Announces First Quarter 2011 Financial Results 4BioMarin Announces First Quarter 2011 Financial Results 5BioMarin Announces First Quarter 2011 Financial Results 6BioMarin Announces First Quarter 2011 Financial Results 7BioMarin Announces First Quarter 2011 Financial Results 8BioMarin Announces First Quarter 2011 Financial Results 9BioMarin Announces First Quarter 2011 Financial Results 10BioMarin Announces First Quarter 2011 Financial Results 11
(Date:7/29/2014)... (GSA) the nation,s largest interdisciplinary organization devoted ... E. Lckenhoff, PhD, of Cornell University as the 2014 ... Foundation Award in Behavioral and Social Gerontology. , This ... in behavioral and social gerontology. Individuals who have received ... The award is given by GSA in conjunction with ...
(Date:7/29/2014)... July 29, 2014 The report ... Cosmetics), Type (Rotary, Volumetric, Aseptic, Net Weight), Process ... Geography - Global Trend & Forecast to 2019”, ... into food, beverage, pharmaceutical, and cosmetic segments with ... each of these segments, in terms of value. ...
(Date:7/29/2014)... Calif. (PRWEB) July 29, 2014 July ... drug abuse directly at the source? That’s the big ... an innovative prescription drug abuse risk program developed by ... hundreds of applicants worldwide to be part of ... 10-12 in San Francisco, CA. The Hive is a ...
(Date:7/29/2014)... -- With the increasing use of electronic medical ... growing demand for a computerized version of the ... States. In a new study, researchers from the ... Institute report that substantial work lies ahead to ... guidelines into computerized prompts for physicians, but the ...
(Date:7/29/2014)... 29, 2014 The Los Angeles ... recently participated in a community program that helps homeless ... volunteers partnered with the San Fernando Valley Rescue Mission ... , The San Fernando Valley Rescue Mission offers emergency ... mission's Family Emergency Shelter provides housing and basic needs ...
Breaking Medicine News(10 mins):Health News:Löckenhoff earns GSA's 2014 Baltes Foundation Award 2Health News:Filling Equipment Market worth $8 Billion by 2019 - Report by MarketsandMarkets 2Health News:Filling Equipment Market worth $8 Billion by 2019 - Report by MarketsandMarkets 3Health News:Filling Equipment Market worth $8 Billion by 2019 - Report by MarketsandMarkets 4Health News:SafeUseNow Selected to Showcase at TEDMED Hive 2014 2Health News:SafeUseNow Selected to Showcase at TEDMED Hive 2014 3Health News:Study: Pediatric preventive care guidelines need retooling for computerized format 2Health News:Study: Pediatric preventive care guidelines need retooling for computerized format 3Health News:The Discovery House Employees Volunteer at Local Rescue Mission 2Health News:The Discovery House Employees Volunteer at Local Rescue Mission 3
... off in Northwestern PA , , HARRISBURG, Pa., June ... the harms of tobacco use on their unborn babies, the ... Control Program are launching a new smoking cessation campaign to ... that region of the state. , , "More ...
... as QM Certified Scoring Partner , , LINCOLN, ... Innoventz, a clinical research organization (CRO) for medical device ... QM Certified Scoring Partner. QualityMetric developed the QM Certified ... many in the life sciences industry -- the accuracy ...
... San Diego, CA, June 22, 2009 Because of ... and children with asthma is recommended by the Advisory ... call for annual influenza vaccination of at least 60% ... for Disease Control and Prevention (CDC) investigators have determined ...
... Mass., June 22 Joseph F. Finn, Jr., C.P.A. ... on developing GCS-100 for treatment of three blood-borne cancers: ... large B cell lymphoma ("DLBCL"). In clinical studies, ... CLL and in combination with existing therapy in MM. ...
... Martha Lucas, Ph.D., L.Ac., Denver-based acupuncturist and practitioner of Traditional ... to Cosmetic Acupuncture for Anti-aging. The announcement is ... tells the history of vanity and what women have been ... Now there,s a healthy, safe option - Cosmetic Acupuncture. ...
... The ... for their own health. Celebrity Diagnosis is an innovative approach to personalized medicine that ... unique feature of Celebrity Diagnosis is the casebook, a convenient and portable information packet ... ...
Cached Medicine News:Health News:State Launches New Campaign to Help Pregnant Smokers Go Tobacco-Free 2Health News:Innoventz Certified to Score Both the SF-36v2 and SF-12v2 Health Surveys 2Health News:Innoventz Certified to Score Both the SF-36v2 and SF-12v2 Health Surveys 3Health News:Adults with asthma not getting their flu shots 2Health News:Prospect Therapeutics Inc.'s GCS-100 Has Focused on Developing Treatment for Three Blood-Borne Cancers 2Health News:Denver-Based Acupuncturist, Dr. Martha Lucas, Releases New Book: 'Vanity Calamity: Your Guide to Cosmetic Acupuncture for Anti-aging' 2Health News:CelebrityDiagnosis.com Presents Famous Patients As Medical Lessons 2Health News:CelebrityDiagnosis.com Presents Famous Patients As Medical Lessons 3
Ideal for abdominal and flank procedures....
Male Abdominal Supporter...
Zippered Abdominal Girdle...
CDIs 2nd Stage Abdominoplasty Girdle - a feminine, easy pull-on version of the 8000 series...
Medicine Products: